Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
AZN

ASTRAZENECA (AZN) stock: insider trades, news & valuation

Health Care · Net selling
Close · Oct 9, 2026 $159.20 +0.3% on the day -5.4% over 12 months 52-week range $155.62 – $208.62

Share price and insider trades

AZN closeInsider buyInsider sale
140160180200220NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $3,248 on 2026-08-08 · Mani SharmaSold $2,209,482 on 2026-05-20 · Mani Sharma
Bought, 12 months$0
Sold, 12 months$2.2M
Insiders buying0
Insiders selling1

ASTRAZENECA insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $2.2M of AZN stock on the open market; P/E 23.8 vs. a sector median of 24.7.

AZN insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $2.2M sold (1 trades)Q2 2026Q3 2026: $3K bought (1 trades)$3KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$3K1—0
Q2 2026—0$2.2M1

Valuation, profit and volume

P/E (trailing)23.8Sector median 24.7
Market value$246.90BDrug Manufacturers - General
Profit margin17.0%Revenue growth +6.4%
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit−$28On all tracked purchases -0.9%

Summary

Over the past 12 months, 0 ASTRAZENECA PLC insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $2.2M. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Members of Congress who traded AZN

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 31, 2026Jul 21, 2026 -19.3%
Alan ArmstrongSenate Bought $15,001 - $50,000 Mar 30, 2026Jul 21, 2026 -17.9%

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 11SEC Mani SharmaSee Remarks Buy 2019,288 held (+0%) $160.57 $3K -0.9% —
May 22SEC Mani SharmaSee Remarks Sell 11,89319,262 held (−38%) $185.78 $2.2M -14.3% —

Insiders at ASTRAZENECA PLC

InsiderBoughtSoldLast filingScore
Mani SharmaSee Remarks $3K $2.2M Sep 11, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

AZN stock: common questions

Are ASTRAZENECA PLC insiders buying AZN stock?

In the past 12 months, 0 insiders reported open-market purchases of AZN worth $0. The latest was See Remarks Mani Sharma bought $3K of AZN at $160.57 — first open-market purchase in our records.

Are ASTRAZENECA PLC insiders selling AZN stock?

1 insiders reported sales worth $2.2M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is AZN's P/E ratio?

AZN trades at about 23.8 times trailing earnings, compared with a median of 24.7 for the Health Care sector.

What is AZN's 52-week range?

Over the past year AZN has traded between $155.62 and $208.62. It last closed at $159.20 on Oct 9, 2026.